|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.550 USD | -3.04% |
|
-12.67% | -75.49% |
| 05-18 | ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-10 | ISpecimen Inc. announced that it has received $2.500004 million in funding | CI |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Revenues | 11.14M | 10.4M | 9.93M | 9.29M | 1.93M | |||
Total Revenues | 11.14M | 10.4M | 9.93M | 9.29M | 1.93M | |||
Cost of Goods Sold, Total | 5.25M | 4.76M | 4.82M | 5.3M | 1.9M | |||
Gross Profit | 5.89M | 5.65M | 5.11M | 3.99M | 24.11K | |||
Selling General & Admin Expenses, Total | 9.97M | 13.18M | 12.71M | 13.19M | 6.84M | |||
R&D Expenses | 1.84M | 2.66M | 3.57M | 3.53M | 2.16M | |||
Other Operating Expenses, Total | 11.81M | 15.83M | 16.28M | 16.72M | 9M | |||
Operating Income | -5.93M | -10.19M | -11.17M | -12.73M | -8.98M | |||
Interest Expense, Total | -2.1M | -239K | -231K | -220K | -9.92K | |||
Interest And Investment Income | 11.4K | 169K | 340K | 44.13K | 3.75K | |||
Net Interest Expenses | -2.09M | -69.62K | 109K | -176K | -6.17K | |||
Other Non Operating Income (Expenses) | 1.27M | 9.78K | -39.1K | 406K | -1.5M | |||
EBT, Excl. Unusual Items | -6.75M | -10.25M | -11.1M | -12.5M | -10.49M | |||
Other Unusual Items | -2.21M | - | - | - | - | |||
EBT, Incl. Unusual Items | -8.96M | -10.25M | -11.1M | -12.5M | -10.49M | |||
Income Tax Expense | - | - | - | - | - | |||
Earnings From Continuing Operations | -8.96M | -10.25M | -11.1M | -12.5M | -10.49M | |||
Net Income to Company | -8.96M | -10.25M | -11.1M | -12.5M | -10.49M | |||
Net Income - (IS) | -8.96M | -10.25M | -11.1M | -12.5M | -10.49M | |||
Net Income to Common Incl Extra Items | -8.96M | -10.25M | -11.1M | -12.5M | -10.49M | |||
Net Income to Common Excl. Extra Items | -8.96M | -10.25M | -11.1M | -12.5M | -10.49M | |||
Per Share Items | ||||||||
Net EPS - Basic | - | -926.81 | -982.08 | -703.27 | -91.15 | |||
Basic EPS - Continuing Operations | - | -926.81 | -982.08 | -703.27 | -91.15 | |||
Basic Weighted Average Shares Outstanding | - | 11.06K | 11.3K | 17.77K | 115K | |||
Net EPS - Diluted | - | -926.81 | -984 | -703.27 | -91.15 | |||
Diluted EPS - Continuing Operations | - | -926.81 | -984 | -703.27 | -91.15 | |||
Diluted Weighted Average Shares Outstanding | - | 11.06K | 11.3K | 17.77K | 115K | |||
Normalized Basic EPS | - | -579.26 | -613.8 | -439.54 | -56.97 | |||
Normalized Diluted EPS | - | -579.26 | -613.8 | -439.54 | -56.97 | |||
Supplemental Items | ||||||||
EBITDA | -5.88M | -10.16M | -11M | -12.47M | -8.72M | |||
EBITA | -5.93M | -10.19M | -11.12M | -12.54M | -8.79M | |||
EBIT | -5.93M | -10.19M | -11.17M | -12.73M | -8.98M | |||
EBITDAR | -5.71M | -9.99M | -10.83M | -12.31M | -8.63M | |||
Effective Tax Rate - (Ratio) | - | - | - | - | - | |||
Normalized Net Income | -4.22M | -6.4M | -6.94M | -7.81M | -6.55M | |||
Interest on Long-Term Debt | 205K | 232K | - | - | - | |||
Supplemental Operating Expense Items | ||||||||
Marketing Expenses | 229K | 188K | 219K | 358K | - | |||
Selling and Marketing Expenses | 2.42M | 3.45M | 3.96M | 4.95M | 2.3M | |||
General and Administrative Expenses | 6.19M | 7.73M | 6.97M | 6.61M | 3.72M | |||
Research And Development Expense From Footnotes | 1.84M | 2.66M | 3.57M | 3.53M | 2.16M | |||
Net Rental Expense, Total | 167K | 176K | 169K | 157K | 85.51K | |||
Imputed Operating Lease Interest Expense | 347K | 187K | 1.63M | 1.08M | 23.36K | |||
Imputed Operating Lease Depreciation | -180K | -10.5K | -1.46M | -928K | 62.16K | |||
Stock-Based Comp., R&D Exp. (Total) | 260K | 132K | 142K | 59.71K | 2.69K | |||
Stock-Based Comp., S&M Exp. (Total) | 55.04K | 93.68K | 66.39K | 47.91K | 9.09K | |||
Stock-Based Comp., G&A Exp. (Total) | 265K | 369K | 196K | 101K | -3.54K | |||
Stock-Based Comp., SG&A Exp. (Total) | 41.48K | 83.95K | 55.37K | 40.64K | 13.02K | |||
Stock-Based Comp., Other (Total) | 12.5K | 6.25K | - | - | - | |||
Total Stock-Based Compensation | 635K | 685K | 460K | 250K | 21.27K |
- Stock Market
- Stocks
- ISPC Stock
- Financials iSpecimen Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















